189.265 articles found

Prodromal Lewy body disorder features in REM sleep behavior disorder with biomarker-defined synucleinopathy

Weintraub D, York MK, Dobkin R, Nair AR, Kurth R, Lafontant D, Caspell-Garcia C, Alcalay RN, Brown EG, Chahine LM, Coffey C, Foroud T, Galasko D, Kieburtz K, Marek K, Merchant K, Mollenhauer B, Poston KL, Siderowf A, Simonet C, Simuni T, Tanner CM, Tropea TF, Videnovic A, Parkinson’s Progression Markers Initiative.

· 2026-01-01

DOI: 10.64898/2025.12.24.25342976

Mesenchymal stem cell membrane camouflaged mesoporous polydopamine for Parkinson's disease treatment via alleviating oxidative stress mediated neuroinflammation

Chen Y, Lv W, Xu J, Li S, Song K, Gong Y, Zhao W, Liu H, Ding Z, Liu L, Yin J, Su D, Lu M, Fang X, Xin H.

Biomaterials · 2026-01-01

Oral efficacy of structurally defined chondroitin sulfate Co-administered with SNAC in Parkinson's disease

Guo Y, Zhang B, Bu C, An Z, Shi D, Jin L, Sheng A, Zhen A, Chi L.

Carbohydrate Polymers. · 2026-01-01

Morphological variation and genetic diversity of breadfruit [Artocarpus altilis (Parkinson) Fosberg] in Vanuatu

Kaoh J, Labouisse JP, Bulememe B, Rivallan R, Garavito A, Lebot V.

Genetic resources and crop evolution. · 2026-01-01

Correction: Unveiling the biochemical potential of Acacia jacquemontii as a therapeutic agent in parkinson’s disease: A multi-model in Vitro, In Vivo, and In Silico Study

Check source for author details

PloS one · 2026-01-01

Neuroprotective effects of empagliflozin and metformin combined therapy on rotenone induced Parkinsonism in Wistar rats via PI3K and PPARγ modulation

Mona M, Borg H, Ahmed A, Abass S, El-Kholy S.

Scientific reports · 2026-01-01

Navigating PINK1 Parkinson’s Disease: Narratives of Pacific Patients and Caregivers

Fa’alau F, Kiadarbandsari A, Foroti M, Roxburgh R, Buchanan C.

Parkinson's disease · 2026-01-01

Longitudinal characterization of biomechanical alterations in a Parkinson's disease mouse model using three-dimensional ground reaction forces

Ning M, Li J, Yang S, Ye M, Fan Y, Dai Z.

Clinical parkinsonism & related disorders · 2026-01-01

Behavioral changes preceded by subthalamic nucleus activity alterations in a progressive macaque model of Parkinson’s disease

Bertrand M, Chabardes S, Hugues Dit Ciles J, De Leiris N, Bastin J, Piallat B.

NPJ Parkinson's disease · 2026-01-01

Amyloid, p‐tau, neurofilament light, and α‐synuclein cerebrospinal fluid biomarkers across Alzheimer's disease, dementia with Lewy bodies, and Parkinson's disease

Rizzo M, Teunissen C, Zetterberg H, Blennow K, Kollmorgen G, Krüger R, Fernandes S, Aarsland D, Borejko O, Hu M, Chokoshvili D, Vijverberg J, Lemstra A, Tijms B, Petzold G, Brockmann K, Gasser T, Frisoni G, Hort J, Nedelska Z, Hopøy A, Fladby T, Jessen F, Düzel E, Spottke A, Höglinger G, Mutel S, Chevalier C, Krishnan R, Visser P, Vos S.

Alzheimer's & dementia (Amsterdam, Netherlands) · 2026-01-01

Anti-osteoporosis medications in persons with and without Parkinson disease in Finland

Leung M, Lamidi M, Tiihonen M, Hartikainen S, Bell J, Turner J, Tolppanen A.

Archives of Osteoporosis · 2026-01-01

Oral sodium butyrate alleviates motor deficits and dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson’s disease rat model

Yang S, Chen Y, Kao T, Kuo C, Chen C, Huang S, Chung S, Fan H, Tsai W.

BMC neuroscience · 2026-01-01